Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Inclusion Criteria: * Have given informed consent by signing and dating an informed consent form (ICF) before initiation of any trial-specific procedures. * Are 18 to 55 years of age inclusive and have a body mass index (BMI) over 18.5 kg/m\^2 and under 35 kg/m\^2 and weigh at least 50 kg. * Are willing and able to comply with scheduled visits, treatment schedule, laboratory tests, lifestyle restrictions, and other requirements of the trial. This includes that they are able to understand and follow trial-related instructions. * Are overall healthy in the clinical judgment of the investigator based on the medical history, clinical assessment (including physical examination, vital signs, clinical laboratory tests, and 12-lead electrocardiogram \[ECG\]), and be interferon gamma release assay (IGRA)-negative for tuberculosis. * Hemoglobin ≥12.0 g/dL for volunteers who were born female, ≥13.0 g/dL for volunteers who were born male. * Volunteers of childbearing potential (VOCBP) that have a negative serum beta-human chorionic gonadotropin pregnancy test result at Visit 0 and negative urine pregnancy test results before each Investigational medicinal product (IMP) injection. Volunteers born female that are postmenopausal (confirmed by follicle stimulating hormone \[FSH\]) or permanently sterilized (verified by medical records) will not be considered VOCBP. * VOCBP who agree to practice a highly effective form of contraception and to require their male partners to use condoms, start…